AHA today urged the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to promptly repay 340B hospitals for unlawful payment cuts in previous years, given the agency’s continued delay in implementing or even proposing a remedy on its own. 
 
After AHA’s unanimous victory in the U.S. Supreme Court this summer, the D.C. court ordered HHS to halt its unlawful 340B cuts for the remainder of 2022. In a final rule released this week for CY 2023, the agency said it would defer any proposal of a remedy for CYs 2018-2021 until sometime before next year’s CY 2024 payment rule. 
 
“Despite having already sought comment twice, HHS has again deferred announcing any specific remedy proposal and indicated that it will solicit a third round of comments,” AHA told the court today. “But no further public comments are needed for the agency to remediate years of illegal underpayments and for Defendants to promptly pay 340B hospitals the difference between ASP plus 6% and what they were previously paid, without seeking retroactive claw backs in the name of budget neutrality. In fact, following this Court’s September 28 Order with respect to the remainder of 2022, Defendants quickly announced that they would cease their illegal conduct and be able to ‘reprocess claims our contractors paid on or after September 28, 2022.’ By swiftly acceding to the Court’s order, HHS fatally undermined its arguments that such an order would be administratively difficult or unconstitutional.”
 

Related News Articles

Headline
The Department of Health and Human Services April 18 finalized its rule to establish a 340B Administrative Dispute Resolution process as required under the…
Headline
Sen. John Thune, R-S.D., April 16 updated AHA members on progress to extend telehealth waivers, offering hope that a solution will arise in end-of-year…
Headline
AHA March 26 submitted comments on a discussion draft of the SUSTAIN 340B Act, legislation proposed in the Senate to clarify Congress’ intent in creating the…
Headline
AHA March 12 released a new report from Healthsperien on discounts to 340B hospitals through the 340B Drug Pricing Program relative to drug company revenues…
Headline
The U.S. Court of Appeals for the 8th Circuit March 12 upheld Arkansas’ 340B Drug Pricing Nondiscrimination Act against a constitutional challenge brought by…
Headline
AHA Feb. 29 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B…